HUP0500345A2 - Készítmények és alkalmazások tüdőrák kezelésére és diagnosztizálására - Google Patents
Készítmények és alkalmazások tüdőrák kezelésére és diagnosztizálásáraInfo
- Publication number
- HUP0500345A2 HUP0500345A2 HU0500345A HUP0500345A HUP0500345A2 HU P0500345 A2 HUP0500345 A2 HU P0500345A2 HU 0500345 A HU0500345 A HU 0500345A HU P0500345 A HUP0500345 A HU P0500345A HU P0500345 A2 HUP0500345 A2 HU P0500345A2
- Authority
- HU
- Hungary
- Prior art keywords
- diagnosis
- polypeptides
- lung cancer
- subject
- treatment
- Prior art date
Links
- 238000003745 diagnosis Methods 0.000 title abstract 4
- 208000020816 lung neoplasm Diseases 0.000 title abstract 4
- 206010058467 Lung neoplasm malignant Diseases 0.000 title abstract 3
- 201000005202 lung cancer Diseases 0.000 title abstract 3
- 238000000034 method Methods 0.000 title abstract 2
- 239000000203 mixture Substances 0.000 title 1
- 238000002560 therapeutic procedure Methods 0.000 title 1
- 229920001184 polypeptide Polymers 0.000 abstract 6
- 102000004196 processed proteins & peptides Human genes 0.000 abstract 6
- 108090000765 processed proteins & peptides Proteins 0.000 abstract 6
- 206010028980 Neoplasm Diseases 0.000 abstract 3
- 102000040430 polynucleotide Human genes 0.000 abstract 3
- 108091033319 polynucleotide Proteins 0.000 abstract 3
- 239000002157 polynucleotide Substances 0.000 abstract 3
- 201000011510 cancer Diseases 0.000 abstract 2
- 239000013604 expression vector Substances 0.000 abstract 2
- 102000004169 proteins and genes Human genes 0.000 abstract 2
- 108090000623 proteins and genes Proteins 0.000 abstract 2
- 238000009007 Diagnostic Kit Methods 0.000 abstract 1
- 210000001744 T-lymphocyte Anatomy 0.000 abstract 1
- 210000004027 cell Anatomy 0.000 abstract 1
- 239000012634 fragment Substances 0.000 abstract 1
- 102000037865 fusion proteins Human genes 0.000 abstract 1
- 108020001507 fusion proteins Proteins 0.000 abstract 1
- 208000037841 lung tumor Diseases 0.000 abstract 1
- 239000000825 pharmaceutical preparation Substances 0.000 abstract 1
- 238000002360 preparation method Methods 0.000 abstract 1
- 230000035755 proliferation Effects 0.000 abstract 1
- 230000000638 stimulation Effects 0.000 abstract 1
- 229960005486 vaccine Drugs 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
Abstract
A találmány tárgyát rákos betegség, pl. tüdőrák kezelése ésdiagnosztizálása képezi. Közelebbről, a találmány tárgyát tüdőtumor-protein legalább egy részletét tartalmazó polipeptidek képezik. Atalálmány tárgyát képezik továbbá a következők: találmány szerintipolipeptideket kódoló polinukleotidok, a polinukleotidokat tartalmazóexpressziós vektorok, az expressziós vektorokkal transzformáltgazdasejtek, találmány szerinti polipeptidhez specifikusan kötődő,izolált antitestek, találmány szerinti polipeptideket tartalmazófúziós proteinek, valamint diagnosztikai készletek. A találmánytárgyát képezik továbbá eljárások tumorproteinre specifikus T-sejtekstimulálására és/vagy szaporítására, valamint a találmány szerintipolipeptidek alkalmazása rák kezelésében és diagnózisában. A találmányszerinti polipeptidek és polinukleotidok alkalmazhatók gyógyászatikészítmények, például, vakcinák és egyéb, tüdőrák diagnosztizálásáraés kezelésére szolgáló készítmények komponenseiként. Ó
Applications Claiming Priority (7)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US53803700A | 2000-03-29 | 2000-03-29 | |
US58893700A | 2000-06-05 | 2000-06-05 | |
US64087800A | 2000-08-18 | 2000-08-18 | |
US23451700P | 2000-09-22 | 2000-09-22 | |
US70451200A | 2000-11-01 | 2000-11-01 | |
US09/738,973 US20020110563A1 (en) | 2000-11-01 | 2000-12-14 | Compositions and methods for the therapy and diagnosis of lung cancer |
PCT/US2001/009991 WO2001072295A2 (en) | 2000-03-29 | 2001-03-28 | Compositions and methods for the therapy and diagnosis of lung cancer |
Publications (1)
Publication Number | Publication Date |
---|---|
HUP0500345A2 true HUP0500345A2 (hu) | 2005-07-28 |
Family
ID=27559252
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HU0500345A HUP0500345A2 (hu) | 2000-03-29 | 2001-03-28 | Készítmények és alkalmazások tüdőrák kezelésére és diagnosztizálására |
Country Status (7)
Country | Link |
---|---|
JP (1) | JP2004526401A (hu) |
AU (1) | AU2001261007A1 (hu) |
CA (1) | CA2404233A1 (hu) |
CZ (1) | CZ20023567A3 (hu) |
HU (1) | HUP0500345A2 (hu) |
PL (1) | PL366626A1 (hu) |
WO (1) | WO2001072295A2 (hu) |
Families Citing this family (40)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20020082212A1 (en) * | 2000-07-20 | 2002-06-27 | Millennium Pharmaceuticals, Inc. | 7716, a novel human ATPase and uses therefor |
WO2002092001A2 (en) * | 2001-05-11 | 2002-11-21 | Corixa Corporation | Compositions and methods for the therapy and diagnosis of lung cancer |
WO2004016733A2 (en) | 2002-08-16 | 2004-02-26 | Agensys, Inc. | Nucleic acid and corresponding protein entitled 251p5g2 useful in treatment and detection of cancer |
US7718787B2 (en) * | 2002-10-18 | 2010-05-18 | Lg Life Sciences Limited | Gene families associated with cancers |
DE10258051A1 (de) * | 2002-12-11 | 2004-07-22 | Metagen Pharmaceuticals Gmbh | Verwendung von an HAT bindenden Substanzen zur Diagnose und Behandlung des Plattenepithelkarzinoms der Lunge |
AU2003295189A1 (en) * | 2002-12-17 | 2004-07-09 | Fondazione Centro San Raffaele Del Monte Tabor | Carcinoembryonic antigen-specific immunodominant epitope recognized by cd4+t cells and uses thereof |
EP1577323B1 (en) | 2002-12-26 | 2013-07-10 | Takeda Pharmaceutical Company Limited | Metastin derivative and use thereof |
CN101845091A (zh) | 2004-06-25 | 2010-09-29 | 武田药品工业株式会社 | 转移素衍生物及其用途 |
GB0512401D0 (en) * | 2005-06-17 | 2005-07-27 | Randox Lab Ltd | Method |
TWI386417B (zh) | 2005-12-22 | 2013-02-21 | Takeda Pharmaceutical | 轉移抑素衍生物及其用途 |
US8404643B2 (en) | 2005-12-22 | 2013-03-26 | Takeda Pharmaceutical Company Limited | Metastin derivatives and use thereof |
JP2007263896A (ja) * | 2006-03-29 | 2007-10-11 | Univ Nagoya | 肺癌患者の術後予後予測のための生物マーカー及びその方法 |
TWI404726B (zh) | 2006-10-25 | 2013-08-11 | Takeda Pharmaceutical | 腫瘤轉移抑制素衍生物及其用途 |
JP5648261B2 (ja) * | 2006-12-20 | 2015-01-07 | 東レ株式会社 | 癌の検出方法 |
PT2325648E (pt) | 2008-08-05 | 2014-06-24 | Toray Industries | Método para detetar cancro |
KR101638490B1 (ko) | 2008-08-05 | 2016-07-11 | 도레이 카부시키가이샤 | 암의 치료 및 예방용 의약 조성물 |
TW201008574A (en) | 2008-08-19 | 2010-03-01 | Oncotherapy Science Inc | INHBB epitope peptides and vaccines containing the same |
MX2011004176A (es) | 2008-10-22 | 2011-09-21 | Oncotherapy Science Inc | Peptido-epitope rab6kifl/kif20a y vacunas que contienen el mismo. |
HUE040012T2 (hu) | 2010-02-04 | 2019-02-28 | Toray Industries | Gyógyászati ágens rák kezelésére és/vagy megelõzésére |
RU2567657C2 (ru) | 2010-02-04 | 2015-11-10 | Торэй Индастриз, Инк. | Фармацевтическая композиция для лечения и/или профилактики рака |
US8911740B2 (en) | 2010-02-04 | 2014-12-16 | Toray Industries, Inc. | Pharmaceutical composition for treating and/or preventing cancer |
HUE030742T2 (hu) | 2010-02-04 | 2017-06-28 | Toray Industries | Gyógyászati készítmény rák kezelésére és/vagy megelõzésére |
PL2532365T3 (pl) | 2010-02-04 | 2016-12-30 | Kompozycja farmaceutyczna do leczenia i/lub zapobiegania nowotworowi | |
PT2532743E (pt) | 2010-02-04 | 2015-08-04 | Toray Industries | Composição farmacêutica para o tratamento e/ou a prevenção de cancro |
AU2012290949B2 (en) | 2011-08-04 | 2017-03-02 | Toray Industries, Inc. | Pharmaceutical composition for treatment and/or prevention of pancreatic cancer |
MX349907B (es) | 2011-08-04 | 2017-08-18 | Toray Industries | Metodo para detectar cancer pancreatico. |
KR101980554B1 (ko) | 2011-08-04 | 2019-05-21 | 도레이 카부시키가이샤 | 암의 치료 및/또는 예방용 의약 조성물 |
RU2610428C2 (ru) | 2011-08-04 | 2017-02-10 | Торэй Индастриз, Инк. | Фармацевтическая композиция для лечения и/или профилактики злокачественной опухоли |
BR112014002621B1 (pt) | 2011-08-04 | 2022-09-20 | Toray Industries, Inc | Anticorpo, ou seu fragmento, composição farmacêutica, uso de um anticorpo e uso de uma composição farmacêutica |
CN103717740B (zh) | 2011-08-04 | 2015-10-21 | 东丽株式会社 | 癌的治疗和/或预防用药物组合物 |
EP2740798B1 (en) | 2011-08-04 | 2016-12-07 | Toray Industries, Inc. | Cancer treatment and/or prevention drug composition |
PL2824114T3 (pl) | 2012-02-21 | 2019-11-29 | Toray Industries | Kompozycja farmaceutyczna do leczenia nowotworu |
ES2749672T3 (es) | 2012-02-21 | 2020-03-23 | Toray Industries | Composición farmacéutica para tratar y/o prevenir el cáncer |
PL2818483T3 (pl) | 2012-02-21 | 2018-01-31 | Toray Industries | Kompozycja lecznicza do leczenia i/lub zapobiegania nowotworowi |
HUE044611T2 (hu) | 2012-02-21 | 2019-11-28 | Toray Industries | Gyógyászati készítmény rák kezelésére |
JP6107654B2 (ja) | 2012-03-30 | 2017-04-05 | 東レ株式会社 | 肝臓癌の治療及び/又は予防用医薬組成物 |
PL2832366T3 (pl) | 2012-03-30 | 2018-04-30 | Toray Industries, Inc. | Kompozycja farmaceutyczna do leczenia i/lub zapobiegania rakowi pęcherzyka żółciowego |
PT2876446T (pt) | 2012-07-19 | 2019-03-25 | Toray Industries | Método para deteção de cancro |
KR102056137B1 (ko) | 2012-07-19 | 2019-12-16 | 도레이 카부시키가이샤 | 암의 검출 방법 |
JP6447130B2 (ja) | 2013-08-09 | 2019-01-09 | 東レ株式会社 | 癌の治療及び/又は予防用医薬組成物 |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5589579A (en) * | 1994-07-19 | 1996-12-31 | Cytoclonal Pharmaceutics, Inc. | Gene sequence and probe for a marker of non-small cell lung carinoma |
CA2296792A1 (en) * | 1999-02-26 | 2000-08-26 | Genset S.A. | Expressed sequence tags and encoded human proteins |
EP1187915A2 (en) * | 1999-04-02 | 2002-03-20 | Corixa Corporation | Compounds for therapy and diagnosis of lung cancer and methods for their use |
AU2001243142A1 (en) * | 2000-02-03 | 2001-08-14 | Hyseq, Inc. | Novel nucleic acids and polypeptides |
WO2001079292A2 (en) * | 2000-04-17 | 2001-10-25 | Pharmacia & Upjohn Company | Novel g protein-coupled receptors |
EP1278844A2 (en) * | 2000-05-03 | 2003-01-29 | PHARMACIA & UPJOHN COMPANY | G protein-coupled receptors |
AU2001269766A1 (en) * | 2000-06-09 | 2001-12-24 | Corixa Corporation | Compositions and methods for the therapy and diagnosis of colon cancer |
-
2001
- 2001-03-28 AU AU2001261007A patent/AU2001261007A1/en not_active Abandoned
- 2001-03-28 WO PCT/US2001/009991 patent/WO2001072295A2/en active Application Filing
- 2001-03-28 HU HU0500345A patent/HUP0500345A2/hu unknown
- 2001-03-28 CA CA002404233A patent/CA2404233A1/en not_active Abandoned
- 2001-03-28 JP JP2001570256A patent/JP2004526401A/ja active Pending
- 2001-03-28 PL PL01366626A patent/PL366626A1/xx not_active Application Discontinuation
- 2001-03-28 CZ CZ20023567A patent/CZ20023567A3/cs unknown
Also Published As
Publication number | Publication date |
---|---|
WO2001072295A3 (en) | 2002-08-22 |
PL366626A1 (en) | 2005-02-07 |
CZ20023567A3 (cs) | 2003-11-12 |
CA2404233A1 (en) | 2001-10-04 |
AU2001261007A1 (en) | 2001-10-08 |
WO2001072295A2 (en) | 2001-10-04 |
JP2004526401A (ja) | 2004-09-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HUP0500345A2 (hu) | Készítmények és alkalmazások tüdőrák kezelésére és diagnosztizálására | |
HUP0302532A2 (hu) | Petefészekrák terápiájában és diagnosztizálásában alkalmazható készítmények és eljárások | |
NZ516381A (en) | Lung tumor proteins in the therapy and diagnosis of lung cancer | |
BR0113491A (pt) | Polinucleotìdeo e polipeptìdeo isolados, vetor de expressão, célula hospedeira, proteìna de fusão, métodos para estimular e/ou expandir células t especìficas para uma protéina de tumor, para estimular uma resposta imune em um paciente, para o tratamento de um câncer em um paciente e para inibir o desenvolvimento de um câncer em um paciente, população de célula t isolada, composição, e, uso de um componente. | |
BR0008161A (pt) | Uso de uma composição terapêutica para tratamento de uma célula tumoral, composição terapêutica, e kit para tratamento de uma célula tumoral | |
ATE353974T1 (de) | Verfahren, zusammensetzungen und kits zur identifizierung und überwachung von brustkrebs | |
HK1022174A1 (en) | Antigen binding fragments that specifically detectcancer cells, nucleotides encoding the fragments, and use thereof for the prophylaxis and detection of cancers | |
TR200103560T2 (tr) | Göğüs kanserinin teşhis ve tedavisi için bileşimler ve bunların kullanımı | |
HUP0002095A2 (hu) | Vegyületek prosztatarák immunterápiás kezelésére és alkalmazásuk | |
BG100771A (en) | Hematopoeic protein and ways and methods for its preparation | |
NO20004631D0 (no) | Forbindelser og fremgangsmÕter for terapi og diagnose av lungekreft | |
ATE416190T1 (de) | Polypeptide mit bindungsaffinität für her2 | |
WO2000060077A3 (en) | Compounds for therapy and diagnosis of lung cancer and methods for their use | |
DE69630890D1 (de) | Peptid-immitierende substanzen in der krebstherapie | |
MX344216B (es) | Productos geneticos expresados de forma diferencial en tumores y su uso. | |
ATE354638T1 (de) | Menschlicher gewebsinhibitor von metalloproteinase-4 | |
BR0108654A (pt) | Composição imunogênica, polipeptìdeo isolado, vetor de expressão ou um microorganismo vivo recombinante, célula hospedeira, processos para produzir uma composição imunogênica e um polipeptìdeo ou um fragmento imunogênico do mesmo, uso de um polipeptìdeo ou de um polinucleotìdeo que codifica um polipeptìdeo, método para o tratamento de um indivìduo pela imunoprofilaxia ou terapia, anticorpo, agonista ou antagonista ao polipeptìdeo, composto, e, processos para diagnosticar, uma doença ou uma suscetibilidade a uma doença e a presença de câncer colorretal ou uma suscetibilidade ao câncer colorretal, em um indivìduo | |
HUP0302566A2 (hu) | Készítmények és eljárások emlőrák gyógykezelésére és diagnosztizálására | |
ATE402956T1 (de) | Neue, mhc klasse ii assoziierte peptide | |
HUP0100267A2 (hu) | Helicobacter pylori eredetű nukleinsav- és aminosav-szekvenciák és a megfelelő nukleinsavakat vagy peptideket tartalmazó vakcina-készítmények | |
BRPI0407031A (pt) | Composições e métodos para tratamento de câncer empregando igsf9 e liv-1 | |
DK1287142T3 (da) | Nukleinsyremolekyle omfattende en for et SDF-1 gamma chemokin, en neuropeptid-præcursor eller mindst et neuropeptid kodende nukleinsyresekvens | |
BR0007816A (pt) | Fator de estimulação óssea | |
WO2002045657A3 (en) | Ovarian tumor antigen and methods of use therefor | |
ATE435284T1 (de) | Zusammensetzungen und verfahren zur therapie und diagnose von lungenkrebs |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FD9A | Lapse of provisional protection due to non-payment of fees |